Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cariprazine in Pediatric Subjects With Bipolar I Disorder
NCT04777357Phase 3Recruiting
- Sponsor
- AbbVie Inc.
- Start
- Apr 2021
- Primary completion
- Mar 2027
- Modality
- Orthosteric Ligands
- Countries
- 3
01
Overview
A Phase 3 trial of cariprazine in bipolar I disorder, sponsored by AbbVie Inc.. Started Apr 2021; status: recruiting.
02
Drugs
cariprazine
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT04777357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04777357.